CariesMiswakNCT02418520
The Effect of Miswak Chewing Sticks on the Oral Helicobacter Pylori Infection
A study testing Miswak in people with Caries and Periodontitis, run by Kuwait University at 1 site in Kuwait.
Trial summary
To elucidate the relationship of chewing miswak sticks on the H. Pylori infection in the oral cavity.The study would be conducted at the Faculty of Dentistry, Kuwait University. Oral plaque samples would be obtained from those patients who are willing to participate. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Caries, Periodontitis
- What is being tested?
- Miswak
- Type of treatment
- Pill or oral medicine, Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteKuwait
- Study dates
- 1 Oct 2019to 1 Dec 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Subjects aged > 18yrs
- Having >24 teeth
- Physically/mentally healthy
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
About this study
To elucidate the relationship of chewing miswak sticks on the H. Pylori infection in the oral cavity.The study would be conducted at the Faculty of Dentistry, Kuwait University.
Oral plaque samples would be obtained from those patients who are willing to participate. As a part of the initial screening the plaque samples would be collected and sent for screening of oral microbiota to the Microbiology Department of Faculty of Dentistry, Kuwait University. Here, the basic microbial culturing (rapid urease test) would be performed for detecting the presence of oral H.Pylori. Volunteers who are tested positive for H. Pylori infection through the rapid urease test would be invited to participate in the study.
Read the detailed description
Ethical aspects The experimental protocol was approved by the Health Science Center (HSC) ethical committee of Kuwait University (VDR/ED/3331) and is registered at ClinicalTrials.gov as NCT02418520 (16/04/2015). Research was conducted according to the principles outlined in the declaration of Helsinki on human medical experimentation. Written informed consent was obtained from all participants and is presented in accordance to the consolidated standards of reporting trials (CONSORT) guidelines.
Study Design This was an experimental study with a randomized, cross-over, single blind design.
Study sample and Data collection This study was conducted among regular patients attending the Dental Center at Kuwait University, Kuwait. Patient recruitment started in February and was completed by the end of August 2019. The PICO (P = Patient population; I = Intervention of interest; C = Comparative intervention; O = Outcome) question for this study was, "for subjects under different fasting conditions (P), what is the effect of using miswak chewing sticks along with toothbrush (I) versus using only toothbrush (C) on the oral H. pylori counts (O)?". Volunteering patients were briefed on the study components and informed consent was obtained from them. Salivary and plaque samples were collected for PCR screening to detect the presence of H. pylori. The inclusion criteria were: 1) subjects with detectable levels of H. pylori in either plaque or salivary samples; 2) no evidence of periodontitis; and, 3) with at least 24 teeth. Subjects who received antibiotic therapy or proton-pump inhibitors within the past three months were excluded from the study.
Recruitment of study participants and grouping This study included 20 subjects who were on 12-hour fasting (fasting group) and 20 subjects who were not fasting (non-fasting group). Non-fasting group subjects were recruited between February and April and fasting group subjects were recruited between May and June 2018 (holy month of Ramadan). At baseline (T0), each subject was assigned numbers based on the chronological order of enrolment in the study. Both, the fasting and the non-fasting subjects were randomly subdivided into Group-1 and Group-2 (n=10 each). Randomized assignment of the subjects was carried out by a random binary outcome of a dice, even or odd numbers. The examiners were kept unaware of the participant allocation. Group-1 subjects were instructed to use both toothbrush and miswak (TB+M) for two weeks (T1) and only toothbrush (TB) for the next two weeks (T2); and, Group-2 subjects were asked to use only TB during T1 and TB+M during T2, for both the fasting and the non-fasting groups. Participants were given instructions on how to use miswak (five finger-grip, scrub technique, for 15 mins, twice daily21) and TB (modified Bass technique, for two minutes, twice daily) by a single investigator (JKB). Plaque and salivary samples were collected at T0, T1 and T2.
Questionnaire The subjects were interviewed and information were collected on their socio-demographic characteristics (age, gender, education, employment and income), presence of selected medical conditions (hypertension, diabetes and current medications), smoking status and dental characteristics (daily brushing frequency and previous dental visit).
Clinical Examination At baseline (T0), three trained and calibrated examiners performed the clinical examinations using a mouth mirror and a manual periodontal probe (CP11 Hu Friedy, Europe), with the patient in semi-supine position on the dental chair (A-dec, Newberg, OR, USA). The clinical examinations assessed the Silness \& Löe plaque index (PI), the Löe \& Silness gingival index (GI), the clinical attachment loss (CAL), the probing depth (PD) and the bleeding on probing (BOP) (inter/intra examiner reliability >80%). These measurements were performed on six surfaces (midlingual/palatal, distolingual/palatal, mesiolingual/palatal, distobuccal, midbuccal, and mesiobuccal) of all teeth. Number of missing teeth were recorded.
Sample collection procedure Plaque and salivary samples were collected from the subjects at T0, T1 and T2. Plaque samples were taken from gingival crevice at deepest pocket reading and removed from the clinical site using a sterile universal curette. The sampling area were isolated using salivary ejectors and gently dried by air. The tip of the curette was inserted into the depths of crevice/pocket, moved coronally while in contact with the tooth surface, to remove both sub and supragingival plaque. The samples were then immersed in 0.5 ml sterile distilled water in Eppendorf tubes (epTIPS Standard, Eppendorf AG, Hamburg, Germany). For the collection of stimulated salivary samples, subjects were requested to chew on paraffin wax and expectorated into a plastic funnel connected to a graded measuring cylinder. About 3 ml of saliva was collected from each subject. Immediately after collection, the sample tubes were placed in a container filled with crushed ice and transported to the Oral Microbiology lab for preserving at -800C.
Bacterial culture H. pylori JA1 strain was obtained from the Faculty of Medicine, KUWAIT University. The bacterial strain was grown on trypticase soy agar supplemented with defibrinated sheep blood (5%) at 37 degree Celsius in microaerophilic conditions.
DNA purification Saliva and plaque samples were brought to the laboratory on ice. After vortexing for 1 minute at 12000 × g, the supernatant was removed, and the pellets were stored at -80°C. DNA from the pellets was purified by using a DNeasy DNA purification Kit (Qiagen, Germany) according to manufacturer's instructions. Briefly, the pellets were treated with lysis buffer and proteinase-K at 56 degree Celsius for 1 h. DNA from lysed samples were applied onto a spin column and washed. Purified DNA was eluted using nuclease free water and the DNA concentrations were measured by UV spectrophotometry method using NanoDropTM 1000. Genomic DNA from H. pylori JA1 was purified by using the same method.
Quantitative real-time polymerase chain reaction (qPCR) After purifying the DNA from the samples, the quantities of H. pylori were measured by SYBR Green quantitative real-time PCR method using H. pylori species-specific primers for ureA gene: ureA-F: 5'-CGTGGCAAGCATGATCCAT-3' and ureA-R: 5'- GGGTATGCACGGTTACGAGTTT-3' 44. The qPCR reaction mixture (25 µl) contained 12.5 µl SYBR Green master mix (Power SYBR Green® Kit, Applied Biosystems), 1.0 µl each of forward and reverse primer (0.4 µM), 5.0 µl DNA template and 5.5 µl H2O. The thermal profile was as follows: an initial denaturation at 95°C for 10min, 40 cycles of 95°C for 15-30s, 55 °C for 30s and 72 °C for 30s. Fluorescent signal acquisition was set at the elongation step of each cycle. All qPCR reactions were run on ABpplied Biosystems® Fast 7500 Real-Time PCR machine. Sequence Detection Systems (SDS) (software version 2.3) was used for data analysis. Serially diluted genomic DNA from H. pylori JA1 was used the reactions for plotting the Ct values against deduced bacterial cell concentration (cells/mL) for each species and to construct standard curves using the above software. All the measurements were taken in triplicate for samples, standards and controls.
Data management and statistical analysis A reduction in the H. pylori count using either TB+M or TB under different fasting conditions was the primary outcome of interest in this study. As no a priori information on the effect of miswak on H. pylori was available, the sample size was calculated to detect a 50% difference between groups, assuming a mean 30% reduction in H. pylori counts between the groups, with a standard deviation of 15%. To obtain a power of 80% and for a risk alpha of 0.05, 17 patients per group were required, which was rounded-off to 20, to account for any potential dropouts. The difference in the microbial counts were computed between T0, T1 and T2. Mann-Whitney U-test or Kruskal-Wallis test (continuous dependent variable) and chi-square test (categorical dependent variable) were used to assess the differences in the general characteristics between the two groups. Distribution of H. pylori between the groups were explored for normality using the Kolmogorov-Smirnov and Shapiro-Wilk tests. The data was not normally distributed, so the intragroup change in H. pylori counts was evaluated with the Wilcoxon signed rank test and the intergroup comparisons were made using the Mann-Whitney U-test. Spearman's test was used to assess the correlation between the H. pylori counts (1x103cells/mL) in plaque/salivary samples and the clinical periodontal parameters at baseline. The level of significance was set to p<0.05. All statistical analyses were carried out using SPSS 26.0 (IBM Corp., Armonk, NY, USA).
- Conditions
- Caries, Periodontitis
- Being tested
- Miswak
- Medical subject headings
- Periodontitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MiswakDevice
Oral hygiene with Miswak chewing sticks and normal tooth brush
| Study group | Role | What they receive |
|---|---|---|
| Miswak chewing | Experimental | Chewing Sticks Receives: Device: Miswak |
| H.Pylori | No intervention | Oral H.Pylori |
What is being measured
The primary outcome is the main question the study is designed to answer.
The main outcome measure would be the change over time of the microbiologic data, specifically the H.Pylori counts within both groups.
The main outcome variable would be the change over time of the microbiologic data within both groups. Thus, the change in the number H.Pylori would be compared between the two groups at regular predetermined intervals.The patients would be recalled regularly and their plaque samples would be collected and sent for 16SrRNA gene sequencing. Gene sequencing has been known to provide more accurate information on the species of Helicobacter when compared to other methods.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Apr 2015 (estimated)
- Study start1 Oct 2019
- Primary completion1 Dec 2019
- Study completion1 Dec 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for CariesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- Intervention group would use Miswak chewing sticks along with the regular use of tooth brush and paste
- Masking
- None (open label)
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kuwait University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dr Jagan K Baskaradoss, Kuwait University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02418520
- Sponsor's protocol ID
- KSAUHS2015
- Acronym
- Miswak
- Status last verified
- Aug 2021
- First submitted
- 9 Apr 2015
- Last updated
- 25 Aug 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Rifaey N, AlAdwani M, Karched M, Baskaradoss JK. A clinical investigation into the efficacy of miswak chewing sticks as an oral hygiene aid: A crossover randomized trial. Int J Dent Hyg. 2021 May;19(2):223-230. doi: 10.1111/idh.12484. Epub 2020 Dec 20.
PubMed 33258168Aksit Bicak D, Akyuz S, Kiratli B, Usta M, Urganci N, Alev B, Yarat A, Sahin F. The investigation of Helicobacter pylori in the dental biofilm and saliva samples of children with dyspeptic complaints. BMC Oral Health. 2017 Mar 21;17(1):67. doi: 10.1186/s12903-017-0361-x.
PubMed 28327128Contractor QQ, Tahir MY, Naseem S, Ahmad S. Helicobacter pylori in the dental plaque of healthy Saudis. Saudi J Gastroenterol. 1998 Jan;4(1):13-6.
PubMed 19864780
Study at a glance
From the registry record, last updated by the sponsor on 25 Aug 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Miswak Chewing Sticks on the Oral Helicobacter Pylori Infection
- ClinicalTrials.gov ID
- NCT02418520
- Acronym / sponsor ID
- Miswak / KSAUHS2015
- Conditions
- Caries, Periodontitis
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- Kuwait UniversityUniversity, hospital or other
- Study start
- 1 Oct 2019 (actual)
- Primary completion
- 1 Dec 2019 (actual)
- Study completion
- 1 Dec 2019 (actual)
- First posted
- 16 Apr 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To elucidate the relationship of chewing miswak sticks on the H. Pylori infection in the oral cavity.The study would be conducted at the Faculty of Dentistry, Kuwait University.
Oral plaque samples would be obtained from those patients who are willing to participate. As a part of the initial screening the plaque samples would be collected and sent for screening of oral microbiota to the Microbiology Department of Faculty of Dentistry, Kuwait University. Here, the basic microbial culturing (rapid urease test) would be performed for detecting the presence of oral H.Pylori. Volunteers who are tested positive for H. Pylori infection through the rapid urease test would be invited to participate in the study.
Detailed description
Ethical aspects The experimental protocol was approved by the Health Science Center (HSC) ethical committee of Kuwait University (VDR/ED/3331) and is registered at ClinicalTrials.gov as NCT02418520 (16/04/2015). Research was conducted according to the principles outlined in the declaration of Helsinki on human medical experimentation. Written informed consent was obtained from all participants and is presented in accordance to the consolidated standards of reporting trials (CONSORT) guidelines.
Study Design This was an experimental study with a randomized, cross-over, single blind design.
Study sample and Data collection This study was conducted among regular patients attending the Dental Center at Kuwait University, Kuwait. Patient recruitment started in February and was completed by the end of August 2019. The PICO (P = Patient population; I = Intervention of interest; C = Comparative intervention; O = Outcome) question for this study was, "for subjects under different fasting conditions (P), what is the effect of using miswak chewing sticks along with toothbrush (I) versus using only toothbrush (C) on the oral H. pylori counts (O)?". Volunteering patients were briefed on the study components and informed consent was obtained from them. Salivary and plaque samples were collected for PCR screening to detect the presence of H. pylori. The inclusion criteria were: 1) subjects with detectable levels of H. pylori in either plaque or salivary samples; 2) no evidence of periodontitis; and, 3) with at least 24 teeth. Subjects who received antibiotic therapy or proton-pump inhibitors within the past three months were excluded from the study.
Recruitment of study participants and grouping This study included 20 subjects who were on 12-hour fasting (fasting group) and 20 subjects who were not fasting (non-fasting group). Non-fasting group subjects were recruited between February and April and fasting group subjects were recruited between May and June 2018 (holy month of Ramadan). At baseline (T0), each subject was assigned numbers based on the chronological order of enrolment in the study. Both, the fasting and the non-fasting subjects were randomly subdivided into Group-1 and Group-2 (n=10 each). Randomized assignment of the subjects was carried out by a random binary outcome of a dice, even or odd numbers. The examiners were kept unaware of the participant allocation. Group-1 subjects were instructed to use both toothbrush and miswak (TB+M) for two weeks (T1) and only toothbrush (TB) for the next two weeks (T2); and, Group-2 subjects were asked to use only TB during T1 and TB+M during T2, for both the fasting and the non-fasting groups. Participants were given instructions on how to use miswak (five finger-grip, scrub technique, for 15 mins, twice daily21) and TB (modified Bass technique, for two minutes, twice daily) by a single investigator (JKB). Plaque and salivary samples were collected at T0, T1 and T2.
Questionnaire The subjects were interviewed and information were collected on their socio-demographic characteristics (age, gender, education, employment and income), presence of selected medical conditions (hypertension, diabetes and current medications), smoking status and dental characteristics (daily brushing frequency and previous dental visit).
Clinical Examination At baseline (T0), three trained and calibrated examiners performed the clinical examinations using a mouth mirror and a manual periodontal probe (CP11 Hu Friedy, Europe), with the patient in semi-supine position on the dental chair (A-dec, Newberg, OR, USA). The clinical examinations assessed the Silness \& Löe plaque index (PI), the Löe \& Silness gingival index (GI), the clinical attachment loss (CAL), the probing depth (PD) and the bleeding on probing (BOP) (inter/intra examiner reliability >80%). These measurements were performed on six surfaces (midlingual/palatal, distolingual/palatal, mesiolingual/palatal, distobuccal, midbuccal, and mesiobuccal) of all teeth. Number of missing teeth were recorded.
Sample collection procedure Plaque and salivary samples were collected from the subjects at T0, T1 and T2. Plaque samples were taken from gingival crevice at deepest pocket reading and removed from the clinical site using a sterile universal curette. The sampling area were isolated using salivary ejectors and gently dried by air. The tip of the curette was inserted into the depths of crevice/pocket, moved coronally while in contact with the tooth surface, to remove both sub and supragingival plaque. The samples were then immersed in 0.5 ml sterile distilled water in Eppendorf tubes (epTIPS Standard, Eppendorf AG, Hamburg, Germany). For the collection of stimulated salivary samples, subjects were requested to chew on paraffin wax and expectorated into a plastic funnel connected to a graded measuring cylinder. About 3 ml of saliva was collected from each subject. Immediately after collection, the sample tubes were placed in a container filled with crushed ice and transported to the Oral Microbiology lab for preserving at -800C.
Bacterial culture H. pylori JA1 strain was obtained from the Faculty of Medicine, KUWAIT University. The bacterial strain was grown on trypticase soy agar supplemented with defibrinated sheep blood (5%) at 37 degree Celsius in microaerophilic conditions.
DNA purification Saliva and plaque samples were brought to the laboratory on ice. After vortexing for 1 minute at 12000 × g, the supernatant was removed, and the pellets were stored at -80°C. DNA from the pellets was purified by using a DNeasy DNA purification Kit (Qiagen, Germany) according to manufacturer's instructions. Briefly, the pellets were treated with lysis buffer and proteinase-K at 56 degree Celsius for 1 h. DNA from lysed samples were applied onto a spin column and washed. Purified DNA was eluted using nuclease free water and the DNA concentrations were measured by UV spectrophotometry method using NanoDropTM 1000. Genomic DNA from H. pylori JA1 was purified by using the same method.
Quantitative real-time polymerase chain reaction (qPCR) After purifying the DNA from the samples, the quantities of H. pylori were measured by SYBR Green quantitative real-time PCR method using H. pylori species-specific primers for ureA gene: ureA-F: 5'-CGTGGCAAGCATGATCCAT-3' and ureA-R: 5'- GGGTATGCACGGTTACGAGTTT-3' 44. The qPCR reaction mixture (25 µl) contained 12.5 µl SYBR Green master mix (Power SYBR Green® Kit, Applied Biosystems), 1.0 µl each of forward and reverse primer (0.4 µM), 5.0 µl DNA template and 5.5 µl H2O. The thermal profile was as follows: an initial denaturation at 95°C for 10min, 40 cycles of 95°C for 15-30s, 55 °C for 30s and 72 °C for 30s. Fluorescent signal acquisition was set at the elongation step of each cycle. All qPCR reactions were run on ABpplied Biosystems® Fast 7500 Real-Time PCR machine. Sequence Detection Systems (SDS) (software version 2.3) was used for data analysis. Serially diluted genomic DNA from H. pylori JA1 was used the reactions for plotting the Ct values against deduced bacterial cell concentration (cells/mL) for each species and to construct standard curves using the above software. All the measurements were taken in triplicate for samples, standards and controls.
Data management and statistical analysis A reduction in the H. pylori count using either TB+M or TB under different fasting conditions was the primary outcome of interest in this study. As no a priori information on the effect of miswak on H. pylori was available, the sample size was calculated to detect a 50% difference between groups, assuming a mean 30% reduction in H. pylori counts between the groups, with a standard deviation of 15%. To obtain a power of 80% and for a risk alpha of 0.05, 17 patients per group were required, which was rounded-off to 20, to account for any potential dropouts. The difference in the microbial counts were computed between T0, T1 and T2. Mann-Whitney U-test or Kruskal-Wallis test (continuous dependent variable) and chi-square test (categorical dependent variable) were used to assess the differences in the general characteristics between the two groups. Distribution of H. pylori between the groups were explored for normality using the Kolmogorov-Smirnov and Shapiro-Wilk tests. The data was not normally distributed, so the intragroup change in H. pylori counts was evaluated with the Wilcoxon signed rank test and the intergroup comparisons were made using the Mann-Whitney U-test. Spearman's test was used to assess the correlation between the H. pylori counts (1x103cells/mL) in plaque/salivary samples and the clinical periodontal parameters at baseline. The level of significance was set to p<0.05. All statistical analyses were carried out using SPSS 26.0 (IBM Corp., Armonk, NY, USA).
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Intervention group would use Miswak chewing sticks along with the regular use of tooth brush and paste
| Arm | Type | Receives |
|---|---|---|
| Miswak chewing | Experimental | Device: MiswakChewing Sticks |
| H.Pylori | No intervention | –Oral H.Pylori |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Subjects aged > 18yrs
- Having >24 teeth
- Physically/mentally healthy
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MiswakOral hygiene with Miswak chewing sticks and normal tooth brush | Device | Miswak chewing |
Primary outcome
The main outcome measure would be the change over time of the microbiologic data, specifically the H.Pylori counts within both groups.
Time frame: 6 months
The main outcome variable would be the change over time of the microbiologic data within both groups. Thus, the change in the number H.Pylori would be compared between the two groups at regular predetermined intervals.The patients would be recalled regularly and their plaque samples would be collected and sent for 16SrRNA gene sequencing. Gene sequencing has been known to provide more accurate information on the species of Helicobacter when compared to other methods.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Aug 2021.
- Background: PubMed 33258168Rifaey N, AlAdwani M, Karched M, Baskaradoss JK. A clinical investigation into the efficacy of miswak chewing sticks as an oral hygiene aid: A crossover randomized trial. Int J Dent Hyg. 2021 May;19(2):223-230. doi: 10.1111/idh.12484. Epub 2020 Dec 20.
- Background: PubMed 28327128Aksit Bicak D, Akyuz S, Kiratli B, Usta M, Urganci N, Alev B, Yarat A, Sahin F. The investigation of Helicobacter pylori in the dental biofilm and saliva samples of children with dyspeptic complaints. BMC Oral Health. 2017 Mar 21;17(1):67. doi: 10.1186/s12903-017-0361-x.
- Results publication: PubMed 19864780Contractor QQ, Tahir MY, Naseem S, Ahmad S. Helicobacter pylori in the dental plaque of healthy Saudis. Saudi J Gastroenterol. 1998 Jan;4(1):13-6.
Related trials for Caries
Active, not recruiting
Trial With Two New Tooth-colored Restorative Materials in Class I/II Cavities
Caries, Defective Restorations
Active, not recruiting
Clinical Evaluation of a New Dual-cure Universal Adhesive
Class I Dental Restorations, Class II Dental Restorations
Not yet recruiting
Safety of Intraosseous Anaesthesia in Children With Haemophilia
Haemophilia A, Haemophilia B
Not yet recruitingObservational study
Diagnostic Performance of Ai vs Junior Dentists
Diagnosis
Not yet recruiting
Clinical and Radiographic Evaluation of Silver Diamine Fluoride Versus Light-Cured Silver Diamine Fluoride in Carious Primary Molars
Dental Caries
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Miswak in people with Caries and Periodontitis, run by Kuwait University at 1 site in Kuwait.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Kuwait. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The main outcome measure would be the change over time of the microbiologic data, specifically the H.Pylori counts within both groups. (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02418520, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Aug 2021.